Shares of eyecare company Bausch + Lomb (NYSE:BLCO) fell 10.6% in the afternoon session after the company announced the voluntary recall of intraocular lenses on its enVista platform. The recall ...

Young Boys' Jordan Siebatcheu, left, scores his side's opening goal against Leverkusen's goalkeeper Niklas Lomb during the Europa League round of 32, 2nd leg soccer match between Bayer 04 ...

Bausch + Lomb has recalled lenses used during cataract surgery due to complications when the lenses are used, according to an announcement from the Canada-based eyecare company posted on the U.S ...

Anyone seeking to report adverse effects should contact Bausch + Lomb at 800-338-2020, option 1, or submit a report to the FDA’s MedWatch program (800-332-1088 to request a form).

Bausch + Lomb said on Friday it would acquire several Novartis eye-care products for $1.75 billion as their market grows, sending the company's shares up over 8% in early trading.

Eyecare company Bausch + Lomb (NYSE:BLCO) will be reporting earnings tomorrow before market open. Here’s what you need to know. Bausch + Lomb beat analysts’ revenue expectations by 1.8% last ...

Bausch + Lomb also delivered full-year 2024 guidance that was better than expected. CEO Brent Saunders said the 2023 results, especially in the fourth quarter, "set the tone" for this year.

Shares of eyecare company Bausch + Lomb (NYSE:BLCO) fell 21.2% in the morning session after the company reported weak first quarter 2025 results: constant currency revenue fell short of Wall ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Bausch + Lomb Will Acquire XIIDRA ® ...

Bausch + Lomb said on Thursday it will recall some of its implantable eye lenses after receiving reports of complications, the cause of which could not immediately be known.

Bausch + Lomb Corp. announced June 30 that it will acquire XIIDRA, a treatment for dry eye disease, from Novartis for up to $2.5 billion.

Shares of Bausch + Lomb (BLCO 2.82%) rallied 15.7% as of 3:07 p.m. ET today. The stock is surging today on news the company is considering selling itself. Of note, ...